We Put Emphasis on Smart,
Innovative Drug Development
Jabez™ Pharma, Inc. ("Jabez") is a drug development company which utilizes collaborative partnerships to develop, manufacture, and market commercially available drug products.
Founded in 2018, the company’s primary focus is the ability to fund and find new and improved, higher levels of science for pharmaceutical prescription purposes for both humans and animals, bringing those ideas to the commercialization stage.
Rather than becoming a standard generics company, our focus is on projects that bring value to the patient through improved medicine, enhanced drug delivery systems and reduced costs.
The Jabez Network of Companies
Uniquely positioned for long-term success in both the Pharmaceutical and Cannabinoid markets, Jabez is committed to utilizing proven scientific methods to produce wellness products through our diverse network of organizations.
Jabez Pharma, Inc.
Jabez Wellness, Inc.
Jabez Phytosciences, Inc.
Jabez Rx, Inc.
Capitalize on existing success and chart a higher trajectory of sustainable profit growth through higher levels of science and technological advancement.
Address unmet medical needs, improve clinical outcomes and build cost-effective healthcare systems by embracing innovation and side-by-side research.
Implement cutting-edge technologies that lead to new treatment alternatives, lowering development costs and shortening development time frames.
Collaborate with our partners to research, create and provide enhanced drug delivery systems.
Generate more success and create value for shareholders through a diverse portfolio of new drugs.
Technical, regulatory, economic and social dynamics are dramatically changing the twenty-first century pharmaceutical world, making it more challenging than ever to develop sustainable and profitable drug-to-market opportunities.
This hyper-competitive and ever evolving drug development company landscape demands unique cost effective solutions. With the over eighty-five years combined experience and success, the Jabez management team’s ability to manage portfolio selection, complex supply chain, compliant API and finished dose global manufacturing and sourcing makes us well-positioned for the future specialty needs of the US patient populations in both the human and animal health sectors.
Through exclusive development and long term relationship partner based strategies with finished dose, formulation, and active pharmaceutical ingredient manufacturers, Jabez will provide the expertise required to ensure the highest standards of quality for our drugs on the market.